|
|
spinal cord development
|
GO:0021510 |
4 |
0.385
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.383
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.329
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.190
|
|
|
|
spinal cord dorsal ventral patterning
|
GO:0021513 |
2 |
0.158
|
|
|
|
positive regulation of mesenchymal stem cell differentiation
|
GO:2000741 |
4 |
0.117
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.116
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.109
|
|
|
|
regulation of mesenchymal stem cell proliferation
|
GO:1902460 |
1 |
0.095
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.092
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.092
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.077
|
|
|
|
positive regulation of digestive system process
|
GO:0060456 |
2 |
0.077
|
|
|
|
cell fate commitment involved in pattern specification
|
GO:0060581 |
1 |
0.075
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.075
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.071
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.070
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.069
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.066
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.065
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.064
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
1 |
0.063
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.063
|
|
|
|
alditol phosphate metabolic process
|
GO:0052646 |
3 |
0.061
|
|
|
|
neuron remodeling
|
GO:0016322 |
2 |
0.059
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.059
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.058
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.058
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.055
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.054
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.054
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.052
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
43 |
0.052
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.052
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.051
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.051
|
|
|
|
abducens nerve development
|
GO:0021560 |
1 |
0.050
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.050
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.049
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.049
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.049
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
1 |
0.047
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.047
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.047
|
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.045
|
|
|
|
embryonic neurocranium morphogenesis
|
GO:0048702 |
1 |
0.045
|
|
|
|
neural tube patterning
|
GO:0021532 |
2 |
0.045
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.043
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.043
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.042
|
|
|
|
water homeostasis
|
GO:0030104 |
14 |
0.041
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.040
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.040
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.040
|
|
|
|
semicircular canal morphogenesis
|
GO:0048752 |
1 |
0.039
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.039
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.038
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.038
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.037
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.036
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.036
|
|
|
|
optokinetic behavior
|
GO:0007634 |
1 |
0.035
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.034
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
1 |
0.034
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.034
|
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.033
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.033
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.032
|
|
|
|
mesenchymal stem cell proliferation
|
GO:0097168 |
1 |
0.032
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.031
|
|
|
|
outer ear morphogenesis
|
GO:0042473 |
2 |
0.031
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.031
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.031
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.030
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.030
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.030
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.030
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
1 |
0.029
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.029
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.029
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.029
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
22 |
0.028
|
|
|
|
regulation of g2 m transition of mitotic cell cycle
|
GO:0010389 |
20 |
0.028
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.028
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.028
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.028
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.028
|
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.028
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.028
|
|
|
|
enteric nervous system development
|
GO:0048484 |
1 |
0.027
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
1 |
0.027
|
|
|
|
axon regeneration
|
GO:0031103 |
1 |
0.026
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.026
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.026
|
|
|
|
brain morphogenesis
|
GO:0048854 |
1 |
0.026
|
|
|
|
epithelial fluid transport
|
GO:0042045 |
1 |
0.025
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.025
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.025
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.025
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.025
|
|
|
|
artery development
|
GO:0060840 |
7 |
0.025
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.024
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.024
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
76 |
0.023
|
|
|
|
semicircular canal formation
|
GO:0060876 |
1 |
0.023
|
|
|
|
regulation of dna replication
|
GO:0006275 |
68 |
0.023
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.023
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.022
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.021
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.021
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.021
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.021
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.021
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
45 |
0.021
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.021
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.021
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.021
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
44 |
0.021
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
1 |
0.020
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.020
|
|
|
|
response to axon injury
|
GO:0048678 |
1 |
0.020
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.020
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.020
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
41 |
0.020
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.020
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.020
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.020
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.020
|
|
|
|
visual behavior
|
GO:0007632 |
2 |
0.019
|
|
|
|
spinal cord patterning
|
GO:0021511 |
2 |
0.019
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.019
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.019
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.019
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.019
|
|
|
|
ear morphogenesis
|
GO:0042471 |
7 |
0.019
|
|
|
|
regulation of dna dependent dna replication
|
GO:0090329 |
19 |
0.019
|
|
|
|
t cell selection
|
GO:0045058 |
4 |
0.018
|
|
|
|
cochlea morphogenesis
|
GO:0090103 |
1 |
0.018
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.018
|
|
|
|
neural tube closure
|
GO:0001843 |
3 |
0.018
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.018
|
|
|
|
pancreas development
|
GO:0031016 |
19 |
0.018
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
41 |
0.018
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.018
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.017
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.017
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.017
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.017
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.017
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.017
|
|
|
|
mammary gland formation
|
GO:0060592 |
1 |
0.017
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.017
|
|
|
|
regulation of atpase activity
|
GO:0043462 |
25 |
0.016
|
|
|
|
artery morphogenesis
|
GO:0048844 |
7 |
0.016
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.016
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
43 |
0.016
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
40 |
0.016
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.016
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.016
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.016
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.016
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.016
|
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.016
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.016
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.016
|
|
|
|
pulmonary artery morphogenesis
|
GO:0061156 |
3 |
0.015
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
119 |
0.015
|
|
|
|
cellular amino acid biosynthetic process
|
GO:0008652 |
30 |
0.015
|
|
|
|
regulation of neuron projection regeneration
|
GO:0070570 |
1 |
0.015
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.015
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.015
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.015
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.015
|
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
1 |
0.015
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
59 |
0.015
|
|
|
|
gene silencing
|
GO:0016458 |
49 |
0.015
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
48 |
0.015
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.014
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.014
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.014
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
25 |
0.014
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.014
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.014
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
1 |
0.014
|
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
4 |
0.014
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.014
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.014
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.014
|
|
|
|
negative regulation of hormone secretion
|
GO:0046888 |
15 |
0.014
|
|
|
|
response to sucrose
|
GO:0009744 |
1 |
0.014
|
|
|
|
positive regulation of dna replication
|
GO:0045740 |
35 |
0.014
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.014
|
|
|
|
inner ear development
|
GO:0048839 |
8 |
0.014
|
|
|
|
golgi to plasma membrane cftr protein transport
|
GO:0043000 |
1 |
0.014
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
14 |
0.014
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.013
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.013
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.013
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.013
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.013
|
|
|
|
carbohydrate phosphorylation
|
GO:0046835 |
17 |
0.013
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.013
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.013
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.013
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.013
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.013
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.013
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
54 |
0.013
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.013
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
41 |
0.013
|
|
|
|
head development
|
GO:0060322 |
108 |
0.013
|
|
|
|
insulin secretion
|
GO:0030073 |
39 |
0.013
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.013
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.013
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.013
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
47 |
0.013
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.013
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.013
|
|
|
|
positive regulation of cell cycle g2 m phase transition
|
GO:1902751 |
8 |
0.012
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.012
|
|
|
|
cell chemotaxis
|
GO:0060326 |
112 |
0.012
|
|
|
|
store operated calcium entry
|
GO:0002115 |
3 |
0.012
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.012
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.012
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.012
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.012
|
|
|
|
regulation of g protein coupled receptor protein signaling pathway
|
GO:0008277 |
35 |
0.012
|
|
|
|
transforming growth factor beta production
|
GO:0071604 |
14 |
0.012
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.012
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.012
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
82 |
0.012
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.012
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
19 |
0.012
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.012
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.012
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.011
|
|
|
|
tube closure
|
GO:0060606 |
3 |
0.011
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
22 |
0.011
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.011
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
1 |
0.011
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.011
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.011
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.011
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.011
|
|
|
|
regulation of dephosphorylation
|
GO:0035303 |
96 |
0.011
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.011
|
|
|
|
release of cytoplasmic sequestered nf kappab
|
GO:0008588 |
4 |
0.011
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.011
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.011
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.011
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.011
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.011
|
|
|
|
cranial nerve formation
|
GO:0021603 |
1 |
0.011
|
|
|
|
dna packaging
|
GO:0006323 |
77 |
0.011
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.011
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.011
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.011
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.011
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.011
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.011
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.011
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.011
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.011
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
71 |
0.011
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.010
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.010
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
64 |
0.010
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.010
|
|
|
|
translation
|
GO:0006412 |
132 |
0.010
|
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.010
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.010
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.010
|
|
|
|
response to fungus
|
GO:0009620 |
4 |
0.010
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.010
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.010
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.010
|
|